Abstract: A system, methods and software for administering and managing experiential learning opportunities (ELOs) are disclosed. The system generally includes a database server storing a relational database containing ELO placement data and records and having an interface configured to communicate with a university computer having a student information database thereon, website server, configured to host an ELO website through which users interact with the relational database, and a memory in the website server, storing a content management system (CMS) that comprises modules and a data pool stored in/on storage nodes on the website server. The modules include a forms module for users to enter ELO data and submit ELO requests, ELO proposals, waivers and agreements, and a timelog module to collect and store timelog data and manage the timelog approval process.

Abstract: The invention is directed to a system and method for collection, distribution and delivery of university student enrollment, progress, and degree completion data, media content, and other data to campus students, faculty, users, employees, and external stakeholders, and more particularly to an integrated distribution system and method that obtains data from multiple sources into a single database, extracts and validates relevant data from the multiple sources and removes legacy formatting and non-essential information, provides user-centric reports, and distributes graphic media from one or more filtered special-purpose user-centric reports that is published to user display devices.

Abstract: Provided is a method of extracting a metal ion, which comprises contacting a compound of formula (R2SiO)n with a source of the metal ion, whereby the compound and the metal ion form a complex, wherein each R is independently C1-10alkyl, and n is 3-10.

Abstract: A system, methods and software for administering and managing experiential learning opportunities (ELOs) are disclosed. The system generally includes a database server storing a relational database containing ELO placement data and records and having an interface configured to communicate with a university computer having a student information database thereon, website server, configured to host an ELO website through which users interact with the relational database, and a memory in the website server, storing a content management system (CMS) that comprises modules and a data pool stored in/on storage nodes on the website server. The modules include a forms module for users to enter ELO data and submit ELO requests, ELO proposals, waivers and agreements, and a timelog module to collect and store timelog data and manage the timelog approval process.

Abstract: A method of purifying an antifreeze protein (AFP) and methods of producing AFPs are disclosed. The method of purifying an AFP includes heating a crude AFP in an aqueous medium to a temperature and for a length of time sufficient to precipitate at least some thermally unstable proteins in the crude AFP and form a precipitate and a supernatant; and removing the precipitate from the supernatant. One method of producing an AFP includes collecting a crude source of the AFP; and purifying the AFP by the purification method. Another method of producing an AFP includes growing or culturing a host configured to express a recombinant AFP in a growth medium, and collecting a crude AFP from the host and/or the growth medium. The growth medium comprises water, a protein hydrolysate or other source of amino acids, a yeast extract, a biologically metabolizable C3-C6 polyol, and one or more phosphate salts.

Abstract: Embodiments of the disclosure pertain to compositions containing (i) one or more non-antifreeze proteins or cell components or cells and (ii) one or more antifreeze proteins (AFPs), mimetics thereof, and/or analogs thereof, and a method of stabilizing a biologic (e.g., a protein, microbe, cell component or cell) against temperature stress and aggregation. The AFP may be selected from known antifreeze polypeptides and antifreeze peptides, analogs and mimetics of antifreeze proteins, active fragments of such antifreeze proteins, polypeptide and peptide mimetics, antifreeze peptoids and polymers, and combinations thereof. The non-antifreeze protein, cell component or cell comprises a known protein, cell component or cell used in the pharmaceutical, medical, agricultural, veterinary and/or food industry(ies). The AFP protects the function of the non-antifreeze protein, microbe(s), cell component(s) or cell(s) under temperature stress (e.g., a temperature of ?20-60° C.).

Abstract: A compound comprising a cyclodextrin and a monoalkoxy polyethylene glycol linked thereto through an ether bond (a “pegylated cyclodextrin”) is disclosed, as are drug delivery vehicles and pharmaceutical formulations including the same, and methods for making the compound and the drug delivery vehicle and for delivering the drug to a patient in need thereof. The method of making includes the steps of creating either a tosylated monoalkoxy polyethylene glycol or a tosylated cyclodextrin, and either reacting the tosylated monoalkoxy polyethylene glycol with a deprotonated cyclodextrin, or reacting the tosylated cyclodextrin with a deprotonated monoalkoxy polyethylene glycol. The present pegylated cyclodextrin readily forms an inclusion compound with certain drugs to protect the drug against adverse interactions with mucin (e.g., in a mucus membrane).

Abstract: Embodiments of the disclosure pertain to compositions containing (i) one or more non-antifreeze proteins or cell components or cells and (ii) one or more antifreeze proteins (AFPs), mimetics thereof, and/or analogs thereof, and a method of stabilizing a biologic (e.g., a protein, microbe, cell component or cell) against temperature stress and aggregation. The AFP may be selected from known antifreeze polypeptides and antifreeze peptides, analogs and mimetics of antifreeze proteins, active fragments of such antifreeze proteins, polypeptide and peptide mimetics, antifreeze peptoids and polymers, and combinations thereof. The non-antifreeze protein, cell component or cell comprises a known protein, cell component or cell used in the pharmaceutical, medical, agricultural, veterinary and/or food industry(ies). The AFP protects the function of the non-antifreeze protein, microbe(s), cell component(s) or cell(s) under temperature stress (e.g., a temperature of ?20-60° C.).

Abstract: The disclosure pertains to compositions to stabilize nutrient, food, pharmaceutical, and biological formulations by preventing the crystallization or precipitation of carbohydrates used in the formulations. The compositions contain (i) one or more carbohydrates, sugars, sugar alcohols, analogs thereof, and/or derivatives thereof and (ii) one or more antifreeze proteins (AFPs), mimetics thereof, and/or analogs thereof and methods of making and using the same. The AFP may be selected from antifreeze polypeptides and antifreeze peptides, analogs and mimetics of antifreeze proteins, active fragments of such antifreeze proteins, polypeptide and peptide mimetics, antifreeze peptoids and polymers, and combinations thereof.